Woodard & CO Asset Management Group Inc Bristol Myers Squibb CO Transaction History

Woodard & CO Asset Management Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $721,874 - $845,582	-12,200 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $56,771 - $61,824	917 Added 8.13%	12,200 $815,000
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $59,933 - $67,407	1,010 Added 9.83%	11,283 $712,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $45,383 - $51,427	786 Added 8.29%	10,273 $637,000
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $32,275 - $35,765	562 Added 6.3%	9,487 $577,000
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $43,965 - $51,400	802 Added 9.87%	8,925 $525,000
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $376,907 - $547,733	8,123 New	8,123 $453,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $14,628 - $18,969	-300 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$59.94 - $65.35 $17,982 - $19,605	300	300 $18,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.